Management of unimmunized contacts of patients with invasive Haemophilus disease.
Sood
S K
SK
Long Island Jewish Medical Center, Albert Einstein College of Medicine, New Hyde Park, NY.
Daum
R S
RS
D016667:Bacterial Capsules; D001425:Bacterial Outer Membrane Proteins / Q000008:administration & dosage; D001428:Bacterial Vaccines / Q000008:administration & dosage*; D002443:Ceftriaxone / Q000008:administration & dosage*; D002675:Child, Preschool; D005260:Female; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae; D006801:Humans; D007114:Immunization; D007223:Infant; D008583:Meningitis, Haemophilus / Q000517:prevention & control*; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage*; D011247:Pregnancy; D012293:Rifampin / Q000008:administration & dosage
D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; C061964:Haemophilus influenzae-type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine; D011135:Polysaccharides, Bacterial; D002443:Ceftriaxone; D012293:Rifampin